Plasmacytoma - 153 Studies Found
| Completed |
: Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting : Multiple Myeloma : 2013-09-17 :
|
| Completed |
: Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma : Multiple Myeloma : 2010-09-09 : Drug: CX-4945 CX-4945 capsules, administered orally,as escalating doses. Dose schedule: four times daily |
| Active, not recruiting |
: Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma :
: 2008-11-14 :
|
| Terminated |
: Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan :
: 2008-01-22 : Other: laboratory biomarker analysis Blood or cheek cells wil be collected. |
| Completed |
: Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma :
: 2006-11-16 : Biological: epoetin alfa Epoetin alfa will be administered 80,000 u sc every week commencing on study da |
| Terminated |
: CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant :
|
| Completed |
: Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma :
: 2005-07-08 :
|
| Completed |
: Vaccine Therapy in Treating Patients With Multiple Myeloma :
|
| Completed |
: Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia :
: 1999-11-01 :
|
| Completed |
: Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma :
: 2008-10-22 : Procedure: allogeneic hematopoietic SCT |